Clinical trial NCT00537147 - References

West Nile Fever — Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults

Citation(s)

•   Chang GJ, Kuno G, Purdy DE, Davis BS
  Recent advancement in flavivirus vaccine development. Expert Rev Vaccines. 2004 Apr;3(2):199-220. Review.
•   Pletnev AG, Claire MS, Elkins R, Speicher J, Murphy BR, Chanock RM
  Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus. Virology. 2003 Sep 15;314(1):190-5.

Phase 1 Study of the Safety and Immunogenicity of a 2-Dose Regimen of West Nile/Dengue 4-3'delta30 Chimeric Virus Vaccine (WN/DEN4delta30), a Live Attenuated Vaccine for West Nile Encephalitis

Details for clinical trial NCT00537147